CervoMed Inc. Common Stock
Symbol: CRVO (NASDAQ)
9.72
▼ (-2.85%) -0.285
Company Description:
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Key Stats
- Today's Open: $10.04
- Today's High: $10.44
- Today's Low: $9.523
- Today's Volume: 159.30K
- Yesterday Close: $10
- Yesterday High: $10.05
- Yesterday Low: $9.68
- Yesterday Volume: 76.39K
- Last Min Volume: 0
- Last Min High: $9.718
- Last Min Low: $9.715
- Last Min VWAP: $0
Company Profile
- Name: CervoMed Inc. Common Stock
- Website: https://www.cervomed.com
- Listed Date: 1996-06-18
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001053691
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $86.94M
- Round Lot: 100
- Outstanding Shares: 8.70M
- Asset Type: CS
RECENT FILINGS FOR CRVO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-20 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 8-K | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-28 | 8-K | View |
| 2025-06-25 | 8-K | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-05-23 | 3 | View |
| 2025-05-19 | 8-K | View |
| 2025-05-14 | 4 | View |
| 2025-05-12 | 424B5 | View |
| 2025-05-12 | 8-K | View |
| 2025-05-12 | 10-Q | View |
Latest News on CRVO